Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

JANXJanux Therapeutics, Inc.

Nasdaq · CIK 0001817713
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts219

Identity from submissions API

NameJanux Therapeutics, Inc.
CIK0001817713
TickersJANX
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN822289112
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 751-4493
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
10955 VISTA SORRENTO PARKWAY
SUITE 200
SAN DIEGO
CA
92130
CA
Mailing address
10955 VISTA SORRENTO PARKWAY
SUITE 200
SAN DIEGO
CA
92130
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

443 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001617201-26-000008 005-92596 261554429 34 16738
2026-11-05 10-Q 10-Q 0001193125-26-449918 001-40475 261527696 34 10374404 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-449790 001-40475 261527272 34 424270 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005493 005-92596 261281489 34 12413
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000200 005-92596 261271726 34 13030
2026-08-06 10-Q 10-Q 0001193125-26-338078 001-40475 261249382 34 10218603 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-337977 001-40475 261248993 34 410370 1 1
2026-07-31 4 xslF345X06/form4-07312026_080701.xml 0001864158-26-000006 4803
2026-07-28 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002544 005-92596 261212565 34 11177
2026-07-10 4 xslF345X06/form4-07102026_080702.xml 0001864158-26-000004 6992
2026-06-23 8-K 8-K 8.01 0001193125-26-279428 001-40475 261111051 34 155184 1 1
2026-06-12 4 xslF345X06/form4-06132026_120640.xml 0001231919-26-000631 18094
2026-06-12 4 xslF345X06/form4-06122026_080611.xml 0001863094-26-000002 8516
2026-06-12 4 xslF345X06/form4-06122026_080609.xml 0001666963-26-000003 7712
2026-06-12 4 xslF345X06/form4-06122026_080607.xml 0001780547-26-000004 7695
2026-06-12 4 xslF345X06/form4-06122026_080605.xml 0001202785-26-000002 7704
2026-06-12 4 xslF345X06/form4-06122026_080604.xml 0001248190-26-000002 7664
2026-06-12 4 xslF345X06/form4-06122026_080601.xml 0001326330-26-000002 7714
2026-06-12 8-K 8-K 5.07 0001193125-26-269387 001-40475 261086623 34 176914 1 1
2026-06-04 4 xslF345X06/form4-06042026_080601.xml 0002069239-26-000005 5368
2026-06-02 144 xsl144X01/primary_doc.xml 0002069239-26-000004 001-40475 261058135 33 4673
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000148 005-92596 26984923 34 12158
2026-05-13 4 xslF345X06/form4-05132026_080505.xml 0002032671-26-000004 4800
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000251 005-92596 26966718 34 8174
2026-05-07 10-Q 10-Q 0001193125-26-212146 001-40475 26954170 34 11080706 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-211964 001-40475 26953580 34 373994 1 1
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001219 005-92596 26946822 34 11248
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002475 005-92596 26918273 34 19521
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002474 005-92596 26918263 34 19521
2026-04-28 8-K 8-K 5.02 0001193125-26-187641 001-40475 26909028 34 158910 1 1
2026-04-28 ARS ARS 0001193125-26-187597 001-40475 26908894 34 26270262
2026-04-28 DEFA14A DEFA14A 0001193125-26-187183 001-40475 26908212 34 2073994
2026-04-28 DEF 14A DEF 14A 0001193125-26-187095 001-40475 26908021 34 6467405 1 1
2026-04-13 144 xsl144X01/primary_doc.xml 0001950047-26-003390 001-40475 26857868 33 6914
2026-04-02 144 xsl144X01/primary_doc.xml 0001950047-26-003195 001-40475 26833189 33 6104
2026-02-26 S-8 S-8 0001193125-26-076970 333-293806 26689905 33 348967 1 1
2026-02-26 10-K 10-K 0001193125-26-076918 001-40475 26689441 34 20460140 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-076627 001-40475 26688099 34 410254 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000086 005-92596 26642384 34 12075
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000058 005-92596 26609552 34 8067
2026-02-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-011545 005-92596 26607987 34 33520
2026-02-04 4 xslF345X05/form4-02052026_010237.xml 0002108554-26-000004 7258
2026-02-04 3 xslF345X02/form3-02052026_010219.xml 0002108554-26-000003 9552
2026-01-26 144 xsl144X01/primary_doc.xml 0001950047-26-000670 001-40475 26560736 33 8307
2026-01-23 144 xsl144X01/primary_doc.xml 0001950047-26-000654 001-40475 26556507 33 6887
2026-01-22 8-K 8-K 1.01,7.01,9.01 0001193125-26-019520 001-40475 26552107 34 223228 1 1
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000045 005-92596 26517687 34 11511
2026-01-02 4 xslF345X05/form4-01022026_090112.xml 0001864159-26-000002 4881
2026-01-02 4 xslF345X05/form4-01022026_090110.xml 0002005618-26-000002 9608
2026-01-02 4 xslF345X05/form4-01022026_090108.xml 0001864158-26-000002 8983
2026-01-02 4 xslF345X05/form4-01022026_090107.xml 0001960264-26-000002 9168
2026-01-02 4 xslF345X05/form4-01022026_090105.xml 0002050056-26-000002 8983
2026-01-02 4 xslF345X05/form4-01022026_090103.xml 0002069239-26-000002 7280
2026-01-02 4 xslF345X05/form4-01022026_090101.xml 0002032671-26-000002 9155
2025-12-15 144 xsl144X01/primary_doc.xml 0001950047-25-010281 001-40475 251571618 33 6168
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009961 001-40475 251556641 33 5452
2025-12-03 4 xslF345X05/form4-12032025_081207.xml 0001864159-25-000006 10807
2025-12-02 144 xsl144X01/primary_doc.xml 0001950047-25-009650 001-40475 251544085 33 4736
2025-12-01 144 xsl144X01/primary_doc.xml 0001950047-25-009526 001-40475 251539932 33 6277
2025-11-14 4 xslF345X05/form4-11142025_081103.xml 0001864159-25-000005 8783
2025-11-14 144 xsl144X01/primary_doc.xml 0001950047-25-008864 001-40475 251486839 33 5549
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000262 005-92596 251461439 34 9579
2025-11-06 10-Q 10-Q 0001193125-25-269799 001-40475 251459110 34 9746731 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-269518 001-40475 251458350 34 396964 1 1
2025-10-30 4 xslF345X05/form4-10302025_081001.xml 0001864159-25-000003 12499
2025-10-28 144 xsl144X01/primary_doc.xml 0001950047-25-008226 001-40475 251425044 33 4823
2025-09-19 8-K 8-K 5.02 0001193125-25-209259 001-40475 251327573 34 153968 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078664 005-92596 251219950 34 12495
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000228 005-92596 251215837 34 9578
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003510 005-92596 251204581 34 12396
2025-08-07 10-Q 10-Q 0000950170-25-105069 001-40475 251194431 34 9875440 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-105010 001-40475 251194006 34 403936 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003076 005-92596 251132240 34 11036
2025-06-13 4 xslF345X05/form4-06132025_110604.xml 0001415889-25-017318 17739
2025-06-13 4 xslF345X05/form4-06132025_070616.xml 0001415889-25-017317 7574
2025-06-13 4 xslF345X05/form4-06132025_070614.xml 0001415889-25-017316 7527
2025-06-13 4 xslF345X05/form4-06132025_070611.xml 0001415889-25-017315 7566
2025-06-13 4 xslF345X05/form4-06132025_070609.xml 0001415889-25-017314 7562
2025-06-13 4 xslF345X05/form4-06132025_070608.xml 0001415889-25-017313 7539
2025-06-13 4 xslF345X05/form4-06132025_070605.xml 0001415889-25-017312 7596
2025-06-13 4 xslF345X05/form4-06132025_070603.xml 0001415889-25-017311 8374
2025-06-13 4 xslF345X05/form4-06132025_070601.xml 0001415889-25-017310 7574
2025-06-13 8-K 8-K 5.07 0000950170-25-086284 001-40475 251047180 34 188816 1 1
2025-06-04 4 xslF345X05/form4-06042025_080616.xml 0001415889-25-015684 7275
2025-05-23 3 xslF345X02/form3-05242025_120554.xml 0001415889-25-014557 7976
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000149 005-92596 25943931 34 9577
2025-05-08 10-Q 10-Q 0000950170-25-067083 001-40475 25926790 34 9264692 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066969 001-40475 25926228 34 364119 1 1
2025-05-02 4 xslF345X05/form4-05022025_080503.xml 0001415889-25-011874 10803
2025-05-01 144 xsl144X01/primary_doc.xml 0001950047-25-002662 001-40475 25903760 33 7004
2025-04-25 ARS ARS 0000950170-25-058822 001-40475 25874870 34 9054138
2025-04-25 DEFA14A DEFA14A 0000950170-25-058809 001-40475 25874805 34 887571
2025-04-25 DEF 14A DEF 14A 0000950170-25-058806 001-40475 25874790 34 7497592 1 1
2025-04-23 4 xslF345X05/form4-04232025_080401.xml 0001415889-25-011243 8519
2025-04-21 144 xsl144X01/primary_doc.xml 0001950047-25-002522 001-40475 25853406 33 6275
2025-03-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-007529 005-92596 25724261 34 22816
2025-03-07 4 xslF345X05/form4-03072025_110328.xml 0001415889-25-007443 20189
2025-03-05 4 xslF345X05/form4-03052025_080309.xml 0001415889-25-007104 10810
2025-03-03 144 xsl144X01/primary_doc.xml 0001950047-25-001426 001-40475 25698368 33 6284
2025-02-27 S-8 S-8 0000950170-25-029185 333-285357 25680320 33 359898 1 1
2025-02-27 10-K 10-K 0000950170-25-029177 001-40475 25680282 34 23388767 1 1
2025-02-27 8-K 8-K 2.02,9.01 0000950170-25-029165 001-40475 25680210 34 401785 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014233 005-92596 25630076 34 12556
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000037 005-92596 25625071 34 9470
2025-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000855 005-92596 25612557 34 15913
2025-02-05 4 xslF345X05/form4-02052025_080201.xml 0001415889-25-003165 12319
2025-02-03 144 xsl144X01/primary_doc.xml 0001950047-25-000570 001-40475 25582763 33 5564
2025-01-08 4 xslF345X05/form4-01082025_080101.xml 0001415889-25-001165 5250
2025-01-07 144 xsl144X01/primary_doc.xml 0001949846-25-000005 001-40475 25514979 33 6973
2025-01-03 4 xslF345X05/form4-01032025_080111.xml 0001415889-25-000677 7313
2025-01-03 4 xslF345X05/form4-01032025_080109.xml 0001415889-25-000676 7744
2025-01-03 4 xslF345X05/form4-01032025_080107.xml 0001415889-25-000675 7315
2025-01-03 4 xslF345X05/form4-01032025_080105.xml 0001415889-25-000674 7307
2025-01-03 4 xslF345X05/form4-01032025_080103.xml 0001415889-25-000673 7862
2025-01-03 4 xslF345X05/form4-01032025_080101.xml 0001415889-25-000672 7511
2025-01-03 3/A xslF345X02/form3a-01042025_010116.xml 0001415889-25-000669 4237
2025-01-03 3 xslF345X02/form3-01042025_010108.xml 0001415889-25-000668 10671
2025-01-03 4 xslF345X05/form4-01032025_050101.xml 0001415889-25-000554 16948
2025-01-02 144 xsl144X01/primary_doc.xml 0001950047-25-000049 001-40475 25502354 33 4831
2024-12-27 4 xslF345X05/form4-12272024_081201.xml 0001415889-24-030211 5253
2024-12-26 144 xsl144X01/primary_doc.xml 0001949846-24-000838 001-40475 241577803 33 6459
2024-12-20 4 xslF345X05/form4-12202024_111213.xml 0001415889-24-029989 10771
2024-12-05 8-K 8-K 8.01,9.01 0001193125-24-271578 001-40475 241529537 34 606299 1 1
2024-12-05 424B5 424B5 0001193125-24-271563 333-279196 241529457 33 656752
2024-12-03 4 xslF345X05/form4-12032024_081201.xml 0001415889-24-028203 4863
2024-12-03 424B5 424B5 0001193125-24-270017 333-279196 241523634 33 637610
2024-12-02 8-K 8-K 7.01,8.01,9.01 0000950170-24-132302 001-40475 241520060 34 13484481 1 1
2024-11-27 4 xslF345X05/form4-11272024_081102.xml 0001415889-24-027905 7151
2024-11-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-002714 005-92596 241462881 34 266083
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118952 005-92596 241462633 34 136869
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258521 005-92596 241461577 34 39472
2024-11-12 SC 13G/A filing.txt 0000315066-24-002789 005-92596 241444857 34 8312
2024-11-08 SC 13D/A SC 13D/A 0001104659-24-116001 005-92596 241442349 34 272946
2024-11-07 4 xslF345X05/form4-11082024_121151.xml 0001415889-24-026386 4858
2024-11-07 4 xslF345X05/form4-11082024_121119.xml 0001415889-24-026385 4803
2024-11-06 10-Q 10-Q 0000950170-24-122370 001-40475 241431406 34 9636486 1 1
2024-11-06 8-K 8-K 2.02,9.01 0000950170-24-122279 001-40475 241430929 34 334660 1 1
2024-11-04 SC 13G/A SC 13G/A 0001193125-24-250609 005-92596 241423454 34 40741
2024-11-01 144 xsl144X01/primary_doc.xml 0001972362-24-001468 001-40475 241419920 33 17860
2024-11-01 144 xsl144X01/primary_doc.xml 0001972362-24-001466 001-40475 241419886 33 15264
2024-11-01 144 xsl144X01/primary_doc.xml 0001957799-24-000300 001-40475 241419464 33 10547
2024-11-01 144 xsl144X01/primary_doc.xml 0001957799-24-000299 001-40475 241419392 33 10675
2024-11-01 144 xsl144X01/primary_doc.xml 0001957799-24-000298 001-40475 241419319 33 10608
2024-11-01 144 xsl144X01/primary_doc.xml 0001957799-24-000297 001-40475 241419117 33 18089
2024-10-30 4 xslF345X05/form4-10302024_071002.xml 0001415889-24-025792 7154
2024-10-28 144 xsl144X01/primary_doc.xml 0001972362-24-001436 001-40475 241401705 33 16632
2024-10-28 144 xsl144X01/primary_doc.xml 0001972362-24-001435 001-40475 241401655 33 14036
2024-10-28 144 xsl144X01/primary_doc.xml 0001957799-24-000288 001-40475 241401488 33 16737
2024-10-25 SC 13D/A SC 13D/A 0001104659-24-111544 005-92596 241397947 34 267841
2024-10-25 144 xsl144X01/primary_doc.xml 0001957799-24-000286 001-40475 241397698 33 9880
2024-10-25 144 xsl144X01/primary_doc.xml 0001957799-24-000285 001-40475 241397624 33 9937
2024-10-25 144 xsl144X01/primary_doc.xml 0001957799-24-000284 001-40475 241397559 33 10000
2024-10-25 144/A xsl144X01/primary_doc.xml 0001972362-24-001426 001-40475 241395870 33 14881
2024-10-24 144 xsl144X01/primary_doc.xml 0001972362-24-001423 001-40475 241393658 33 12809
2024-10-24 144 xsl144X01/primary_doc.xml 0001972362-24-001421 001-40475 241393391 33 15331
2024-10-24 4 xslF345X05/form4-10242024_041001.xml 0001415889-24-025601 24040
2024-10-23 144 xsl144X01/primary_doc.xml 0001957799-24-000283 001-40475 241390198 33 9323
2024-10-23 SC 13G SC 13G 0001104659-24-110907 005-92596 241390180 34 67276
2024-10-23 144 xsl144X01/primary_doc.xml 0001957799-24-000282 001-40475 241390175 33 9265
2024-10-23 144 xsl144X01/primary_doc.xml 0001957799-24-000281 001-40475 241389920 33 9211
2024-10-23 144 xsl144X01/primary_doc.xml 0001957799-24-000280 001-40475 241389601 33 14798
2024-10-22 4 xslF345X05/form4-10222024_041001.xml 0001415889-24-025502 13867
2024-10-22 SC 13D/A SC 13D/A 0001104659-24-110569 005-92596 241386515 34 86467
2024-10-22 SC 13D/A SC 13D/A 0001104659-24-110567 005-92596 241386502 34 358256
2024-10-21 144 xsl144X01/primary_doc.xml 0001972362-24-001415 001-40475 241383905 33 14026
2024-10-21 144 xsl144X01/primary_doc.xml 0001957799-24-000278 001-40475 241383773 33 14138
2024-10-21 144 xsl144X01/primary_doc.xml 0001972362-24-001414 001-40475 241382773 33 11635
2024-10-18 4 xslF345X05/form4-10182024_101021.xml 0001415889-24-025436 70435
2024-10-18 144 xsl144X01/primary_doc.xml 0001957799-24-000277 001-40475 241381302 33 8541
2024-10-18 144 xsl144X01/primary_doc.xml 0001957799-24-000276 001-40475 241381240 33 8593
2024-10-18 144 xsl144X01/primary_doc.xml 0001957799-24-000275 001-40475 241381159 33 8656
2024-10-17 144 xsl144X01/primary_doc.xml 0001972362-24-001411 001-40475 241378268 33 12723
2024-10-17 144 xsl144X01/primary_doc.xml 0001972362-24-001410 001-40475 241377859 33 10400
2024-10-17 144 xsl144X01/primary_doc.xml 0001957799-24-000273 001-40475 241377792 33 12821
2024-10-16 144 xsl144X01/primary_doc.xml 0001972362-24-001409 001-40475 241375594 33 11387
2024-10-16 144 xsl144X01/primary_doc.xml 0001957799-24-000272 001-40475 241375464 33 7921
2024-10-16 144 xsl144X01/primary_doc.xml 0001972362-24-001408 001-40475 241375442 33 9318
2024-10-16 144 xsl144X01/primary_doc.xml 0001957799-24-000271 001-40475 241375430 33 7978
2024-10-16 144 xsl144X01/primary_doc.xml 0001957799-24-000270 001-40475 241375376 33 8387
2024-10-16 144 xsl144X01/primary_doc.xml 0001957799-24-000269 001-40475 241375307 33 11506
2024-09-30 4 xslF345X05/form4-10012024_121033.xml 0001415889-24-024119 65156
2024-09-30 144 xsl144X01/primary_doc.xml 0001972362-24-001389 001-40475 241340601 33 8018
2024-09-30 144 xsl144X01/primary_doc.xml 0001972362-24-001387 001-40475 241340578 33 10153
2024-09-30 144 xsl144X01/primary_doc.xml 0001957799-24-000259 001-40475 241339621 33 9854
2024-09-27 4 xslF345X05/form4-09272024_110955.xml 0001415889-24-024078 9105
2024-09-27 4 xslF345X05/form4-09272024_110948.xml 0001415889-24-024076 7333
2024-09-27 4 xslF345X05/form4-09272024_110948.xml 0001415889-24-024074 9046
2024-09-27 144 xsl144X01/primary_doc.xml 0001972362-24-001385 001-40475 241336218 33 8713
2024-09-27 144 xsl144X01/primary_doc.xml 0001957799-24-000258 001-40475 241335871 33 7266
2024-09-27 144 xsl144X01/primary_doc.xml 0001972362-24-001382 001-40475 241335706 33 6724
2024-09-27 144 xsl144X01/primary_doc.xml 0001957799-24-000257 001-40475 241335656 33 7141
2024-09-27 144 xsl144X01/primary_doc.xml 0001957799-24-000256 001-40475 241335655 33 7203
2024-09-27 144 xsl144X01/primary_doc.xml 0001950047-24-007420 001-40475 241335213 33 4847
2024-09-27 144 xsl144X01/primary_doc.xml 0001957799-24-000255 001-40475 241335112 33 8869
2024-09-27 144 xsl144X01/primary_doc.xml 0001949846-24-000591 001-40475 241334879 33 4385
2024-09-27 144 xsl144X01/primary_doc.xml 0001950047-24-007418 001-40475 241334789 33 4765
2024-09-26 144 xsl144X01/primary_doc.xml 0001957799-24-000254 001-40475 241330010 33 7051
2024-09-26 144 xsl144X01/primary_doc.xml 0001957799-24-000253 001-40475 241329907 33 6626
2024-09-26 144 xsl144X01/primary_doc.xml 0001957799-24-000252 001-40475 241329774 33 6472
2024-09-16 SC 13D/A SC 13D/A 0001104659-24-100347 005-92596 241302389 34 361628
2024-09-16 SC 13D/A SC 13D/A 0001104659-24-100346 005-92596 241302381 34 176921
2024-09-13 144 xsl144X01/primary_doc.xml 0001972362-24-001340 001-40475 241298491 33 5544
2024-09-12 144 xsl144X01/primary_doc.xml 0000048966-24-000026 001-40475 241296279 33 5781
2024-09-12 144 xsl144X01/primary_doc.xml 0000048966-24-000025 001-40475 241296268 33 5809
2024-09-12 144 xsl144X01/primary_doc.xml 0000048966-24-000024 001-40475 241296232 33 5624
2024-09-12 4 xslF345X05/form4-09132024_120915.xml 0001415889-24-023337 26572
2024-09-12 144 xsl144X01/primary_doc.xml 0001972362-24-001337 001-40475 241295975 33 7377
2024-09-12 144/A xsl144X01/primary_doc.xml 0001957799-24-000230 001-40475 241295533 33 7640
2024-09-11 144/A xsl144X01/primary_doc.xml 0001957799-24-000228 001-40475 241291787 33 6322
2024-09-10 144 xsl144X01/primary_doc.xml 0001178937-24-000056 001-40475 241291106 33 5165
2024-09-10 144 xsl144X01/primary_doc.xml 0001178937-24-000055 001-40475 241291082 33 5188
2024-09-10 144 xsl144X01/primary_doc.xml 0001178937-24-000054 001-40475 241291071 33 5067
2024-09-10 144 xsl144X01/primary_doc.xml 0001972362-24-001317 001-40475 241291003 33 6151
2024-09-10 4 xslF345X05/form4-09102024_090952.xml 0001415889-24-023153 32179
2024-09-10 144 xsl144X01/primary_doc.xml 0001957799-24-000227 001-40475 241290235 33 4920
2024-09-09 144 xsl144X01/primary_doc.xml 0001972362-24-001303 001-40475 241288266 33 5497
2024-09-09 144 xsl144X01/primary_doc.xml 0001972362-24-001301 001-40475 241288256 33 4309
2024-09-09 144/A xsl144X01/primary_doc.xml 0001957799-24-000225 001-40475 241287100 33 4349
2024-09-09 144 xsl144X01/primary_doc.xml 0001957799-24-000224 001-40475 241286870 33 4263
2024-09-06 144 xsl144X01/primary_doc.xml 0001178937-24-000053 001-40475 241285585 33 4518
2024-09-06 144 xsl144X01/primary_doc.xml 0001178937-24-000052 001-40475 241285576 33 4534
2024-09-06 144 xsl144X01/primary_doc.xml 0001178937-24-000051 001-40475 241285568 33 4474
2024-08-09 3 xslF345X02/form3-08092024_110859.xml 0001415889-24-021058 14733
2024-08-09 SC 13D/A AMENDMENT NO. 2 0000947871-24-000668 005-92596 241192823 34 218572
2024-08-07 10-Q 10-Q 0000950170-24-092857 001-40475 241184248 34 10486968 1 1
2024-08-07 8-K 8-K 2.02,9.01 0000950170-24-092830 001-40475 241184140 34 344305 1 1
2024-07-24 4/A xslF345X05/form4a-07242024_080704.xml 0001415889-24-020057 7473
2024-07-24 4/A xslF345X05/form4a-07242024_080702.xml 0001415889-24-020056 7446
2024-07-22 4 xslF345X05/form4-07232024_120738.xml 0001415889-24-019904 11458
2024-07-22 4 xslF345X05/form4-07232024_120716.xml 0001415889-24-019903 11431
2024-07-22 3 xslF345X02/form3-07232024_120747.xml 0001415889-24-019902 7962
2024-07-22 3 xslF345X02/form3-07232024_120759.xml 0001415889-24-019901 7939
2024-07-22 8-K 8-K 5.02,9.01 0000950170-24-085321 001-40475 241132151 34 213527 1 1
2024-06-28 4 xslF345X05/form4-06282024_080632.xml 0001415889-24-018452 17742
2024-06-28 4 xslF345X05/form4-06282024_040646.xml 0001415889-24-018443 11748
2024-06-28 4 xslF345X05/form4-06282024_040643.xml 0001415889-24-018442 7595
2024-06-28 4 xslF345X05/form4-06282024_040641.xml 0001415889-24-018441 7573
2024-06-28 4 xslF345X05/form4-06282024_040639.xml 0001415889-24-018440 7561
2024-06-28 4 xslF345X05/form4-06282024_040637.xml 0001415889-24-018439 7573
2024-06-28 4 xslF345X05/form4-06282024_040635.xml 0001415889-24-018438 8369
2024-06-28 4 xslF345X05/form4-06282024_040633.xml 0001415889-24-018437 7526
2024-06-28 8-K 8-K 5.07 0000950170-24-079059 001-40475 241085870 34 178426 1 1
2024-06-17 DEFA14A DEFA14A 0001193125-24-162678 001-40475 241049133 34 30430
2024-06-05 SC 13D/A SC 13D/A 0001104659-24-068766 005-92596 241023492 34 253644
2024-06-05 4 xslF345X05/form4-06052024_110623.xml 0001415889-24-015678 11718
2024-06-05 4 xslF345X05/form4-06052024_110615.xml 0001415889-24-015676 9507
2024-06-05 4 xslF345X05/form4-06052024_110653.xml 0001415889-24-015673 13937
2024-06-03 144 xsl144X01/primary_doc.xml 0001178937-24-000026 001-40475 241015566 33 4514
2024-06-03 144 xsl144X01/primary_doc.xml 0001178937-24-000025 001-40475 241015546 33 4993
2024-06-03 144 xsl144X01/primary_doc.xml 0001178937-24-000024 001-40475 241015524 33 4528
2024-05-08 S-3ASR S-3ASR 0001193125-24-133838 333-279196 24924475 33 1174975
2024-05-08 10-Q 10-Q 0000950170-24-054966 001-40475 24923892 34 8919583 1 1
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-054950 001-40475 24923869 34 304039 1 1
2024-04-29 ARS ARS 0000950170-24-049923 001-40475 24891400 34 9517443
2024-04-29 DEFA14A DEFA14A 0000950170-24-049893 001-40475 24891160 34 2368523
2024-04-29 DEF 14A DEF 14A 0000950170-24-049873 001-40475 24890995 34 1471650
2024-03-08 S-8 S-8 0000950170-24-028694 333-277797 24735178 33 160764
2024-03-08 10-K 10-K 0000950170-24-028659 001-40475 24734705 34 14947630 1 1
2024-03-08 8-K 8-K 2.02,9.01 0000950170-24-028647 001-40475 24734446 34 371793 1 1
2024-03-06 SC 13D/A SC 13D/A 0001104659-24-031587 005-92596 24727624 34 113699
2024-03-06 4 xslF345X05/form4-03062024_040318.xml 0001415889-24-007006 13866
2024-03-04 SC 13D/A SC 13D/A 0001104659-24-030638 005-92596 24717769 34 246040
2024-03-04 4 xslF345X05/form4-03052024_120347.xml 0001415889-24-006428 25738
2024-03-04 4 xslF345X05/form4-03042024_090343.xml 0001415889-24-006305 4852
2024-03-04 4 xslF345X05/form4-03042024_090300.xml 0001415889-24-006293 4797
2024-02-29 424B5 424B5 0001193125-24-053696 333-266720 24705329 33 615613
2024-02-29 8-K 8-K 8.01,9.01 0000950170-24-023257 001-40475 24705029 34 842309 1 1
2024-02-29 FWP FWP 0000950170-24-022579 333-266720 24698560 34 133575
2024-02-28 8-K 8-K 8.01 0000950170-24-022266 001-40475 24696857 34 164484 1 1
2024-02-28 424B5 424B5 0001193125-24-048573 333-266720 24689871 33 543744
2024-02-27 8-K 8-K 8.01 0000950170-24-021425 001-40475 24688672 34 179010 1 1
2024-02-26 8-K 8-K 7.01,9.01 0000950170-24-020183 001-40475 24679239 34 17552213 1 1
2024-02-14 SC 13G/A janx13ga.htm 0000935836-24-000211 005-92596 24640976 34 46854
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023965 005-92596 24640028 34 137840
2024-02-14 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-24-000443 005-92596 24633239 34 277107
2024-02-09 SC 13G/A SC 13G/A 0001193125-24-030116 005-92596 24615517 34 39447
2024-02-09 SC 13G/A filing.txt 0000315066-24-001237 005-92596 24611752 34 8227
2024-02-01 SC 13G/A SC 13G/A 0001193125-24-021859 005-92596 24587121 34 40895
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000440 5572
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000438 5562
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000435 5561
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000433 5574
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000431 5567
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000426 5573
2024-01-03 3 FORM 3 SUBMISSION 0001209191-24-000419 13151
2023-11-16 SC 13D/A SC 13D/A 0001193125-23-278039 005-92596 231411883 34 296297
2023-11-15 4 FORM 4 SUBMISSION 0001209191-23-055352 6731
2023-11-15 4 FORM 4 SUBMISSION 0001209191-23-055349 8004
2023-11-13 4 FORM 4 SUBMISSION 0001209191-23-055083 11607
2023-11-07 10-Q 10-Q 0000950170-23-060288 001-40475 231384226 34 10827272 1 1
2023-11-07 8-K 8-K 2.02,9.01 0000950170-23-060238 001-40475 231383730 34 402997 1 1
2023-09-07 144 xsl144X01/primary_doc.xml 0001972362-23-000786 001-40475 231243286 33 4928
2023-08-14 144 xsl144X01/primary_doc.xml 0001972362-23-000645 001-40475 231171145 33 4204
2023-08-08 10-Q 10-Q 0000950170-23-039898 001-40475 231151985 34 12631872 1 1
2023-08-08 8-K 8-K 2.02,8.01,9.01 0000950170-23-039843 001-40475 231151601 34 453830 1 1
2023-07-21 4 OWNERSHIP DOCUMENT 0001104659-23-083069 16747
2023-07-18 424B5 424B5 0001193125-23-188936 333-266720 231095082 33 583484
2023-07-18 8-K 8-K 1.01,8.01,9.01 0001193125-23-188867 001-40475 231094442 34 571927 1 1
2023-07-17 FWP FWP 0001193125-23-187711 333-266720 231090576 34 25636
2023-07-17 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-23-187702 001-40475 231090569 34 2516058 1 1
2023-07-10 SC 13G SC 13G 0001104659-23-079647 005-92596 231079736 34 150085
2023-06-23 8-K 8-K 5.02 0000950170-23-029662 001-40475 231038273 34 189695 1 1
2023-06-20 8-K 8-K 3.01,5.07 0000950170-23-028982 001-40475 231026365 34 208002 1 1
2023-06-16 4 OWNERSHIP DOCUMENT 0001104659-23-072338 13809
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037989 5523
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037987 5531
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037984 6187
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037981 5509
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037978 5495
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037975 5461
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037972 5509
2023-05-30 SC 13G SCHEDULE 13G 0000921895-23-001386 005-92596 23977192 34 285413
2023-05-09 8-K 8-K 1.01,9.01 0000950170-23-019856 001-40475 23903431 34 771921 1 1
2023-05-09 424B5 424B5 0001193125-23-139520 333-266720 23903246 33 477708
2023-05-09 10-Q 10-Q 0000950170-23-019689 001-40475 23902212 34 11524992 1 1
2023-05-09 8-K 8-K 2.02,9.01 0000950170-23-019641 001-40475 23902006 34 403196 1 1
2023-04-28 ARS ARS 0000950170-23-015940 001-40475 23867986 34 15445555
2023-04-28 DEFA14A DEFA14A 0000950170-23-015925 001-40475 23867694 34 2334948
2023-04-28 DEF 14A DEF 14A 0000950170-23-015919 001-40475 23867577 34 2878216
2023-03-31 8-K 8-K 5.02 0000950170-23-011433 001-40475 23788989 34 189885 1 1
2023-03-10 S-8 S-8 0000950170-23-007323 333-270470 23724371 33 235904
2023-03-10 10-K 10-K 0000950170-23-007311 001-40475 23724224 34 19261172 1 1
2023-03-10 8-K 8-K 2.02,9.01 0000950170-23-007286 001-40475 23723796 34 471847 1 1
2023-02-10 SC 13G/A SC 13G/A 0001193125-23-032697 005-92596 23612633 34 39126
2023-02-09 SC 13G/A JHG PLC OWNS <5% 0001274173-23-000022 005-92596 23604688 34 10076
2023-02-09 SC 13G/A filing.txt 0000315066-23-001809 005-92596 23603032 34 8134
2023-01-23 SC 13G janx13g.htm 0000935836-23-000053 005-92596 23542031 34 47150
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001886 5458
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001885 5448
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001882 5447
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001878 5457
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001872 5445
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001867 5459
2023-01-05 3 FORM 3 SUBMISSION 0001209191-23-001862 9871
2022-11-10 10-Q 10-Q 0000950170-22-024511 001-40475 221377631 34 11584771 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024472 001-40475 221377320 34 492267 1 1
2022-09-22 4 FORM 4 SUBMISSION 0001209191-22-051047 7877
2022-09-22 3 FORM 3 SUBMISSION 0001209191-22-051046 5969
2022-09-22 8-K 8-K 5.02,9.01 0000950170-22-018774 001-40475 221259758 34 247674 1 1
2022-09-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-09-19 16:00:00 9999999995-22-002748 333-266720 221252012 33 1736
2022-09-15 CORRESP filename1.htm 0000950170-22-018541 15722
2022-08-11 UPLOAD filename1.pdf 0000000000-22-008551 40213
2022-08-09 S-3 S-3 0001193125-22-216311 333-266720 221149413 33 1355189
2022-08-09 10-Q 10-Q 0000950170-22-016082 001-40475 221148607 34 10635010 1 1
2022-08-09 8-K 8-K 2.02,9.01 0000950170-22-016068 001-40475 221148477 34 474759 1 1
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037453 5424
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037449 5376
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037445 5446
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037442 6029
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037436 5439
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037431 5410
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037428 5416
2022-06-16 4 OWNERSHIP DOCUMENT 0001104659-22-071933 12107
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037424 6102
2022-06-15 8-K 8-K 5.07 0000950170-22-011646 001-40475 221016297 34 203050 1 1
2022-05-10 10-Q 10-Q 0000950170-22-008984 001-40475 22909868 34 9436445 1 1
2022-05-10 8-K 8-K 2.02,9.01 0000950170-22-008972 001-40475 22909683 34 393242 1 1
2022-05-02 8-K 8-K 8.01,9.01 0000950170-22-006779 001-40475 22879475 34 5573576 1 1
2022-04-29 DEFA14A DEFA14A 0000950170-22-006746 001-40475 22877184 34 2301926
2022-04-29 DEF 14A DEF 14A 0000950170-22-006742 001-40475 22876627 34 1201934
2022-03-18 S-8 FORM S-8 0000950123-22-003537 333-263712 22753277 33 216336
2022-03-18 10-K 10-K 0000950170-22-004171 001-40475 22753073 34 17069063 1 1
2022-03-18 8-K 8-K 2.02,9.01 0000950170-22-004161 001-40475 22752687 34 429240 1 1
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015616 5399
2022-03-03 3 FORM 3 SUBMISSION 0001209191-22-015606 5995
2022-02-14 SC 13G JANUS HENDERSON GROUP PLC OWNS 5.8% OF JANUX THERAPEUTICS 0001274173-22-000083 005-92596 22623504 34 10529
2022-02-11 SC 13G SC 13G 0001193125-22-036944 005-92596 22620583 34 37689
2022-01-10 SC 13G filing.txt 0000315066-22-000036 005-92596 22520729 34 8374
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001833 5415
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001830 5396
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001827 5409
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001818 5383
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001813 5408
2021-12-30 4 xslF345X03/ownership.xml 0000947871-21-001323 12648
2021-12-30 4 xslF345X03/ownership.xml 0000947871-21-001322 9089
2021-12-23 4 xslF345X03/ownership.xml 0000947871-21-001315 12648
2021-12-23 4 xslF345X03/ownership.xml 0000947871-21-001314 9091
2021-12-17 4 xslF345X03/ownership.xml 0000947871-21-001300 9091
2021-12-17 4 xslF345X03/ownership.xml 0000947871-21-001299 12656
2021-12-17 SC 13D/A AMENDMENT NO. 1 0000947871-21-001298 005-92596 211502490 34 140607
2021-11-09 10-Q 10-Q 0000950170-21-003738 001-40475 211392169 34 8698866 1 1
2021-11-09 8-K 8-K 2.02,9.01 0000950170-21-003727 001-40475 211391982 34 425680 1 1
2021-10-01 8-K 8-K 1.01,2.03 0000950170-21-001977 001-40475 211299716 34 177206 1 1
2021-09-09 4 FORM 4 SUBMISSION 0001209191-21-055346 5410
2021-09-09 4 FORM 4 SUBMISSION 0001209191-21-055341 5430
2021-09-09 3 FORM 3 SUBMISSION 0001209191-21-055339 5953
2021-09-09 3 FORM 3 SUBMISSION 0001209191-21-055330 5929
2021-09-09 8-K 8-K 5.02 0000950170-21-001745 001-40475 211245051 34 189508 1 1
2021-08-27 8-K 8-K 1.01,2.03 0000950170-21-001576 001-40475 211219300 34 164351 1 1
2021-08-10 10-Q 10-Q 0000950170-21-001188 001-40475 211160278 34 6960322 1 1
2021-08-10 8-K 8-K 2.02,9.01 0000950170-21-001172 001-40475 211159919 34 403757 1 1
2021-07-20 3 FORM 3 SUBMISSION 0001209191-21-047387 7488
2021-07-16 8-K 8-K 5.02 0001193125-21-217455 001-40475 211095789 34 17560
2021-06-25 SC 13G SC 13G 0001193125-21-199391 005-92596 211044641 34 40941
2021-06-25 SC 13D SC 13D 0001193125-21-199387 005-92596 211044634 34 239585
2021-06-22 SC 13D SCHEDULE 13D 0000947871-21-000708 005-92596 211032681 34 146917
2021-06-16 4 FORM 4 SUBMISSION 0001209191-21-041062 21113
2021-06-16 4 FORM 4 SUBMISSION 0001209191-21-041058 21506
2021-06-16 4 FORM 4 SUBMISSION 0001209191-21-041054 24864
2021-06-16 4 FORM 4 SUBMISSION 0001209191-21-041041 14553

Latest XBRL company facts

One latest value per concept from companyfacts (219 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 61.18M 2026-11-03 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
dei EntityPublicFloat Entity Public Float USD 1.10B 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-076918
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD -4.03M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187095
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 4.61M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187095
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 135.46 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187095
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD -17.75M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187095
ecd PeoTotalCompAmt PeoTotalCompAmt USD 13.51M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187095
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 104.78 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187095
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 7.50M 2024-06-30 2024 Q2 10-Q 2024-08-07 0000950170-24-092857
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 8.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 20.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 85,000 2021-06-30 2021 Q2 10-Q 2021-08-10 0000950170-21-001188
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 8.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -6.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.34B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 26.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 17,000 2024-04-01 2024-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-105069
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 11.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap Assets Assets USD 983.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AssetsCurrent Assets, Current USD 959.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 940.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 91,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 6.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 910.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 300,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 570.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 903.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 41.82M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 36.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 42.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -10.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 23.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 61.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 61.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap CommonStockValue Common Stock, Value, Issued USD 61,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -78.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 8.00M 2020-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 27.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 50,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 202.17M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029177
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 18,000 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029177
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 74.53M 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029177
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 206,000 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029177
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 84.50M 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029177
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 224,000 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029177
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 124 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029177
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 5.96M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 95.97M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 27.65M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 5.96M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 42.02M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 154,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 15.32M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 5.86M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 90.01M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 90,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 778,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 967,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.03 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap Depreciation Depreciation USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.32 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-008984
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.192 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 1.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.033 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 47.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss Financing Receivable, Accrued Interest, before Allowance for Credit Loss USD 6.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 32.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ImpairedFinancingReceivableRelatedAllowance Impaired Financing Receivable, Related Allowance USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029177
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap IncentiveFromLessor Incentive from Lessor USD 700,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 21.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -23.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 3.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -415,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -677,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 411,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 27.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 1.70M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-09 0000950170-21-003738
us-gaap IncreaseDecreaseInNotesReceivableRelatedParties Increase (Decrease) in Notes Receivable, Related Parties USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 3.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap InterestAndOtherIncome Interest and Other Income USD 29.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 6.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 25.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 8.86M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 4.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 4.06M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap Liabilities Liabilities USD 72.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 983.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap LiabilitiesCurrent Liabilities, Current USD 54.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 6.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 7.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -25.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -67.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 29.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 120.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -97.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingLeaseLeaseIncomeLeasePayments Operating Lease, Lease Income, Lease Payments USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 20.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 17.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 16.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024511
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 596,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -10.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -10.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-008984
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 334.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 477,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 13.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 342.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.54M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-212146
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -67.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 11.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.79M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 411,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 88.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap RestrictedCash Restricted Cash USD 816,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 816,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -419.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 23.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 26.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.83 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-08 0000950170-24-054966
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.018 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-10 0000950170-21-001188
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 38.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 14.76 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 11.26 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 0 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 45.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 16.78 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 45.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 9.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 16.78 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 10,319 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.57 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 10.4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 24.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 13.83 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap SharesOutstanding Shares, Outstanding shares 61.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap ShortTermInvestments Short-term Investments USD 903.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 911.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.281 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap StockIssued1 Stock Issued USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024511
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 581,449 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 591,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 204.17M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 20,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 6.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2021-12-31 2021 FY 10-K 2022-03-18 0000950170-22-004171
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 5.48M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 50,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007311
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 23.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076918
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 62.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 41.32M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-008984
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 62.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449918

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →